Dalchimpharm

Dalchimpharm is a leading Russian pharmaceutical manufacturer headquartered in Khabarovsk, serving as one of the oldest and largest drug production facilities in the Russian Far East. Established in 1939, the company specializes in the large-scale production of essential medicines, including generic small molecule drugs in various forms such as ampoules, tablets, and topical solutions. Its extensive product portfolio covers a wide range of therapeutic areas including infectious diseases, pain management, and cardiovascular health. Dalchimpharm operates fully integrated manufacturing cycles and plays a critical role in the regional supply of government-subsidized and hospital-grade medications. The company is structured as a public joint-stock company and continues to modernize its facilities to meet contemporary Good Manufacturing Practice (GMP) standards.